Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity
- 1 September 1989
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (9), 1652-1653
- https://doi.org/10.1128/aac.33.9.1652
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranesBiochemistry, 1988
- Nomenclature of LY146032Journal of Antimicrobial Chemotherapy, 1988
- Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1987
- The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococciJournal of Antimicrobial Chemotherapy, 1987
- Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032Antimicrobial Agents and Chemotherapy, 1987
- Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendationsAntimicrobial Agents and Chemotherapy, 1987
- Effect of calcium on in vitro activity of LY146032 against Clostridium difficileAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1985